ELMD: Strong growth, high margins, and new clinical guidelines drive expansion in airway clearance
A profitable, debt-free medtech firm with a unique airway clearance device is leveraging new clinical guidelines, strong payer coverage, and direct-to-patient sales to drive double-digit growth and high margins. Strategic investments in R&D and sales expansion support continued outperformance.Based…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.